Skip to main content
. 2022 Nov 28;27(6):1914–1925. doi: 10.1007/s10461-022-03925-w

Table 2.

Association between stigma and engagement in HIV care among 306 HIV-positive women who inject drugs participants, Kyiv, Ukraine, November 2019–November 2020

OR (95% CI) aOR (95% CI)
Internalized stigma
 Neither stigma in both categories Reference Reference
 Drug use stigma only 0.44 (0.21, 0.91)*** 0.40 (0.18, 0.89)*
 HIV stigma only 0.57 (0.24, 1.36) 0.79 (0.32, 1.97)
 Both drug use and HIV status 0.38 (0.22, 0.65)*** 0.54 (0.31, 0.95)*
Enacted Stigma
 Neither stigma in both categories Reference Reference
 Drug use stigma only 0.57 (0.30, 1.07) 0.49 (0.24, 0.98)*
 HIV stigma only a a
 Both drug use and HIV status 0.51 (0.27, 0.96)* 0.44 (0.21, 0.89)*
Age
 Less than 34 years Reference Reference
 34 years or older 1.49 (0.95, 2.34)* 1.13 (0.68, 1.88)
Has any children
 No Reference Reference
 Yes 1.65 (1.02, 2.66)* 1.58 (0.94, 2.66)
Time since HIV diagnosis
 Less than 5 years Reference Reference
 5 years or more 2.25 (1.42, 3.57)** 2.31 (1.36, 3.94)*
Injects drugs almost daily or more
 No Reference Reference
 Yes 0.68 (0.43, 1.08) 0.72 (0.44, 1.18)

*p < 0.05, **p < 0.01, ***p < 0.001

aOdds ratios not calculated for enacted HIV stigma group due to small cell sizes